Blog
RSS FeedPosted by Michael Wonder on 15 Dec 2018
Price disclosure 2019 April cycle outcomes summary
14 December 2018 - The summary of price disclosure price reductions for the 2019 April Cycle has now been published. ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...
Posted by Michael Wonder on 12 Nov 2018
Drug prices on ads: as ‘relevant’ as percent daily value on food labels
9 November 2018 - President Trump announced late last month that his administration will push back on high drug costs ...
Posted by Michael Wonder on 25 Oct 2018
Pharmaceutical industry challenges Trump plan forcing companies to reveal drug prices in TV ads
25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off ...
Posted by Michael Wonder on 23 Oct 2018
Drug prices in advertisements actually hurt consumers
23 October 2018 - This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs ...
Posted by Michael Wonder on 22 Oct 2018
Trump and his team fight for health consumers, starting with drug price transparency
22 October 2018 - Drugs like EpiPen have exorbitant prices due to price gouging. The Trump administration is taking steps to ...
Posted by Michael Wonder on 16 Oct 2018
Drug price transparency won’t end the patent games
17 October 2018 - Just look at Humira, which is keeping its U.S. monopoly as generics hit the European market. ...
Posted by Michael Wonder on 16 Oct 2018
CMS proposes to require manufacturers to disclose drug prices in television ads
15 October 2018 - Proposed rule would further the Trump Administration’s commitment to lower prescription drug prices by requiring companies ...
Posted by Michael Wonder on 10 Oct 2018
Why it's not so simple to standardise the guides insurers use to pay for off-label cancer drugs
10 October 2018 - In accordance with federal law, CMS must reimburse cancer drugs used off-label if one of five ...
Posted by Michael Wonder on 10 Oct 2018
Trump signs bills aimed at increasing drug price transparency
10 October 2018 - President Donald Trump signed two pieces of legislation into law on Wednesday that aim to inform ...
Posted by Michael Wonder on 01 Oct 2018
Congratulations. Your study went nowhere.
23 September 2018 - Researchers should embrace negative results instead of accentuating the positive, which is one of several biases that ...
Posted by Michael Wonder on 26 Sep 2018
Pharmacists may soon be able to tell you the cheapest way to get prescriptions
26 September 2018 - Some pharmacists blocked by PBMs from revealing lower prices. ...
Posted by Michael Wonder on 25 Sep 2018
To include or not include drug prices in DTC advertisements
24 September 2018 - For quite some time, consumer groups, patient advocates, and even several medical professional societies have called ...
Posted by Michael Wonder on 06 Sep 2018
Is it time for a review of the content in PBAC Public Summary Documents?
7 September 2018 - Important content is either not reported or not reported in a consistent manner. ...
Posted by Michael Wonder on 06 Sep 2018
Senate unanimously passes bill banning pharmacy 'gag clauses' in Medicare
5 September 2018 - The Senate unanimously passed a bill Wednesday that would ban Medicare insurers from enforcing “gag clauses” ...